Neuroplasticity failure in Alzheimer's disease: Bridging the gap between plaques and tangles

Neuron

Volumn 24, Issue 3, 1999, Pages 521-529

  Mesulam, M Marsel ^a  

^a NORTHWESTERN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; ESTROGEN; PRESENILIN 1; PRESENILIN 2;

AGING; ALZHEIMER DISEASE; COGNITIVE DEFECT; HUMAN; NERVE CELL PLASTICITY; NEUROFIBRILLARY TANGLE; NEUROPATHOLOGY; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; SENILE PLAQUE;

EID: 0033230623     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(00)81109-5     Document Type: Review

References (111)

1. Agnati, L.F., Zoli, M., Biagini, G., and Fuxe, K. (1992). Neuronal plasticity and ageing processes in the frame of the 'Red Queen Theory'. Acta Physiol. Scand. 145, 301-309.
2. Almkvist, O., Basun, H., Wagner, S.L., Rowe, B.A., Wahlund, L.-O., and Lannfelt, L. (1997). Cerebrospinal fluid levels of α-secretase-cleaved soluble amyloid precursor protein mirror cognition in a Swedish family with Alzheimer disease and a gene mutation. Arch. Neurol. 54, 641-644.
3. Arendt, T., Brückner, M.K., Bigl, V., and Marcova, L. (1995). Dendritic reorganization in the basal forebrain under degenerative conditions and its defects in Alzheimer's disease. III. The basal forebrain compared with other subcortical areas. J. Comp. Neurol. 351, 223-246.
4. Arendt, T., Schindler, C., Brückner, M.K., Eschrich, K., Bigl, V., Zedlick, D., and Marcova, L. (1997). Plastic neuronal remodeling is impaired in patients with Alzheimer's disease carrying apolipoprotein ∈4 allele. J. Neurosci. 17, 516-529.
5. Arendt, T., Brückner, M.K., Gertz, H.-J., and Marcova, L. (1998). Cortical distribution of neurofibrillary tangles in Alzheimer's disease matches the pattern of neurons that retain their capacity of plastic remodeling in the adult brain. Neuroscience 83, 991-1002.
6. Arnold, S.E., Hyman, B.T., Flory, J., Damasio, A.R., and van Hoesen, G.W. (1991). The topographical and neuroanatomical distribution of neurofibrillary tangles and neuritic plaques in the cerebral cortex of patients with Alzheimer's disease. Cereb. Cortex 1, 103-116.
7. Arriagada, P.V., Growdon, J.H., Hedley-Whyte, E.T., and Hyman, B.T. (1992). Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer's disease. Neurology 42, 631-639.
8. Banati, R.B., Gehrmann, J., Czech, C., Monning, U., Jones, L.L., Konig, G., Beyreuther, K., and Kreutzberg, G.W. (1993). Early and de novo synthesis of Alzheimer beta A4-amyloid precursor protein (APP) in activated microglia. Glia 9, 199-210.
9. Barton, A.J., Harrison, P.J., Najlerahim, A., Haffernan, J., McDonald, B., Robinson, J.R., Davies, D.C., Harrison, W.J., Mitra, P., and Hardy, J.A. (1990). Increased tau messenger RNA in Alzheimer's disease hippocampus. Am. J. Pathol. 137, 497-502.
10. Baskerville, K.A., Schweitzer, J.B., and Herron, P. (1997). Effects of cholinergic depletion on experience-dependent plasticity in the cortex of the rat. Neuroscience 80, 1159-1169.
11. Beeson, J.G., Shelton, E.R., Chan, H.W., and Gage, F.H. (1994). Age and damage induced changes in amyloid protein precursor immunohistochemistry in the rat brain. J. Comp. Neurol. 342, 69-77.
12. Black, M.M., Slaughter, T., Moshiach, S., Obrocka, M., and Fischer, I. (1996). Tau is enriched on dynamic microtubules in the distal region of growing axons. J. Neurosci. 16, 3601-3619.
13. Black, J.E., Polinsky, M., and Greenough, W.T. (1989). Progressive failure of cerebral angiogenesis supporting neural plasticity in aging rats. Neurobiol. Aging 10, 353-358.
14. Bliss, T.V., and Collingridge, G.L. (1993). A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31-39.
15. Braak, H., and Braak, E. (1996). Evolution of the neuropathology of Alzheimer's disease. Acta Neurol. Scand. 165 (suppl.), 3-12.
16. Brion, J.-P., Octave, J.N., and Couck, A.M. (1994). Distribution of the phosphorylated microtubule-associated protein tau in developing cortical neurons. Neuroscience 63, 895-909.
17. Buell, S.J., and Coleman, P.D. (1979). Dendritic growth in the aged human brain and failure of growth in senile dementia. Science 206, 854-856.
18. Busciglio, J., Ferreira, A., Steward, O., and Caceres, A. (1987). An immunocytochemical and biochemical study of the microtubule-associated protein tau during post-lesion afferent reorganization in the hippocampus of adult rats. Brain Res. 419, 244-252.
19. Calhoun, M.E., Jucker, M., Martin, L.J., Thinakaran, G., Price, D.L., and Mouton, P.R. (1996). Comparative evaluation of synaptophysin-based methods for quantitation of synapses. J. Neurocytol. 25, 821-828.
20. Calhoun, M.E., Wiederhold, K.H., Abramowski, D., Phinney, A.L., Probst, A., Sturchler-Pierrat, C., Staufenbiel, M., Sommer, B., and Jucker, M. (1998). Neuron loss in APP transgenic mice. Nature 395, 755-756.
21. Chapman, P.F., White, G.L., Jones, M.J., Cooper-Blacketer, D., Marshall, V.J., Irizarry, M., Younkin, L., Good, M.A., Bliss, T.V.P., Hyman, B.T., et al. (1999). Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice. Nat. Neurosci. 2, 271-276.
22. Chauvet, N., Apert, C., Dumoulin, A., Epelbaum, J., and Alonso, G. (1997). Mab22C11 antibody to amyloid precursor protein recognizes a protein associated with specific astroglial cells of the rat central nervous system characterized by their capacity to support axonal outgrowth. J. Comp. Neurol. 377, 550-564.
23. Cotman, C.W., and Nieto-Sampedro, M. (1984). Cell biology of synaptic plasticity. Science 225, 1287-1294.
24. Cummings, B.J., Pike, C.J., Shankle, R., and Cotman, C.W. (1996). β-amyloid deposition and other measures of neuropathology predict cognitive status in Alzheimer's disease. Neurobiol. Aging 17, 921-933.
25. Davis, D.G., Schmitt, A., Wekstein, D.R., and Merkesberry, W.R. (1999). Alzheimer neuropathologic alterations in aged cognitively normal subjects. J. Neuropathol. Exp. Neurol. 58, 376-388.
26. Delacourte, A., David, J.P., Sergeant, N., Buée, L., Wattez, A., Vermersch, P., Ghozali, F., Fallet-Bianco, C., Pasquier, F., Lebert, F., et al. (1999). The biochemical pathway of neurofibrillary degeneration in aging and Alzheimer's disease. Neurology 52, 1158-1165.
27. Drubin, D.G., Feinstein, S.C., Shooter, E.M., and Kirschner, M.W. (1985). Nerve growth factor-induced neurite outgrowth in PC12 cells involves the coordinate induction of microtubule assembly and assembly-promoting factors. J. Cell Biol. 101, 1799-1807.
28. Duff, K. (1997). Alzheimer transgenic mouse models come of age. Trends Neurosci. 20, 279-280.
29. Esmaeli-Azad, B., McCarty, J.H., and Feinstein, S.C. (1994). Sense and antisense transfection analysis of tau function: tau influences net microtubule assembly, neurite outgrowth and neuritic stability. J. Cell Sci. 107, 869-879.
30. Ferreira, A., and Caceres, A. (1991). Estrogen-enhanced neurite growth: evidence for a selective induction of Tau and stable microtubules. J. Neurosci. 11, 392-400.
31. Florence, S.L., Taub, H.B., and Kaas, J.H. (1998). Large-scale sprouting of cortical connections after peripheral injury in adult macaque monkeys. Science 282, 1117-1121.
32. Fox, N.C., Warrington, E.K., Seiffer, A.L., Agnew, S.K., and Rossor, M.N. (1998). Presymptomatic cognitive deficits in individuals at risk of familial Alzheimer's disease: a longitudinal prospective study. Brain 121, 1631-1639.
33. Francis, P.T., Palmer, A.M., Sims, N.R., Bowen, D.M., Davison, A.N., Esiri, M.M., Neary, D., Snowden, J.S., and Wilcock, G.K. (1985). Neurochemical studies of early-onset Alzheimer's disease. Possible influence on treatment. N. Engl. J. Med. 313, 7-11.
34. Furukawa, K., Guo, Q., Schellenberg, G.D., and Mattson, M.P. (1998). Presenilin-1 mutation alters NGF-induced neurite outgrowth, calcium homeostasis, and transcription factor (AP-1) activation in PC12 cells. J. Neurosci. Res. 52, 618-624.
35. Galasko, D., Clark, C., Chang, L., Miller, B., Green, R.C., Motter, R., and Seubert, P. (1997). Assessment of CSF levels of tau protein in mildly demented patients with Alzheimer's disease. Neurology 48, 632-635.
36. Games, D., Adams, D., Alessandrini, R., Barbour, R., Berthelette, P., Blackwell, C., Carr, T., Clemens, J., Donaldson, T., Gillespie, F., et al. (1995). Alzheimer-type neuropathology in transgenic mice over-expressing V717F β-amyloid precursor protein. Nature 373, 523-527.
37. Geddes, J.F., Vowles, G.H., Robinson, S.F., and Sutcliffe, J.C. (1996). Neurofibrillary tangles, but not Alzheimer-type pathology, in a young boxer. Neuropathol. Appl. Neurobiol. 22, 12-16.
38. Geinisman, Y., Morrell, F., and de Toledo-Morrell, L. (1989). Perforated synapses on double-headed dendritic spines: a possible structural substrate of synaptic plasticity. Brain Res. 480, 326-329.
39. Gertz, H.-J., Krüger, H., Patt, S., and Cervos-Navarro, J. (1990). Tangle-bearing neurons show more extensive dendritic trees than tangle-free neurons in area CA1 of the hippocampus in Alzheimer's disease. Brain Res. 548, 260-266.
40. Geula, C., and Mesulam, M.-M. (1999). Cholinergic systems in Alzheimer's disease. In Alzheimer Disease, R.D. Terry et al., eds. (Philadelphia: Lippincott Williams & Wilkins), pp. 269-292.
41. Giannakopoulos, P., Hof, P.R., Michel, J.P., Guimon, J., and Bouras, C. (1997). Cerebral cortex pathology in aging and Alzheimer's disease: a quantitative survey of large hospital-based geriatric and psychiatric cohorts. Brain Res. Rev. 25, 217-245.
42. Giannakopoulos, P., Gold, G., Duc, M., Michel, J.-P., Hof, P.R., and Bouras, C. (1999). Neuroanatomical correlates of visual agnosia in Alzheimer's disease. A clinicopathologic study. Neurology 52, 71-77.
43. Glanzman, D.L., Kandel, E.R., and Schacher, S. (1990). Target-dependent structural changes accompanying long-term synaptic facilitation in Aplysia neurons. Science 249, 799-802.
44. Gómez-Isla, T., Price, J.L., McKeel, D.W., Jr., and Morris, J.C. (1996). Profound loss of layer II entorhinal cortex neurons occurs in very mild Alzheimer's disease. J. Neurosci. 16, 4491-4500.
45. Gómez-Isla, T., Hollister, R., West, H., Mui, S., Growdon, J.H., Petersen, R.C., Parisi, J.E., and Hyman, B.T. (1997). Neuronal loss correlates with but exceeds neurofibrillary tangles in Alzheimer's disease. Ann. Neurol. 41, 17-24.
46. Hardy, J. (1997). Amyloid, the presenilins and Alzheimer's disease. Trends Neurosci. 20, 154-159.
47. Huber, G., Bailly, Y., Martin, J.R., Mariani, J., and Brugg, B. (1997). Synaptic β-amyloid precursor proteins increase with learning capacity in rats. Neuroscience 80, 313-320.
48. Hyman, B.T., and Trojanowski, J.Q. (1997). Editorial on consensus recommendations for the postmortem diagnosis of Alzheimer's disease from the National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. J. Neuropathol. Exp. Neurol. 56, 1095-1097.
49. Ishida, A., Furukawa, K., Keller, J.N., and Mattson, M.P. (1997). Secreted form of β-amyloid precursor protein shifts the frequency dependency for induction of LTD, and enhances LTP in hippocampal slices. Neuroreport 8, 2133-2137.
50. Kang, D.E., Soriano, S., Frosch, M.P., Collins, T., Naruse, S., Sisodia, S.S., Leibowitz, G., Levine, F., and Koo, E.H. (1999). Presenilin 1 facilitates the constitutive turnover of beta-catenin: differential activity of Alzheimer's disease-linked PS1 mutants in the beta-catenin-signaling pathway. J. Neurosci. 19, 4229-4237.
51. Kawas, C., Resnick, S., Morrison, A., Brookmeyer, R., Corrada, M., Zonderman, A., Bacal, C., Lingle, D.D., and Metter, E. (1997). A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: the Baltimore longitudinal study of aging. Neurol. 48, 1517-1521.
52. Kempermann, G., Brandon, E.P., and Gage, F.H.(1998). Environmental stimulation of 129/SvJ mice causes increased cell proliferation and neurogenesis in the adult dentate gyrus. Curr. Biol. 8, 939-942.
53. Kilgard, M.P., and Merzenich, M.M. (1998). Cortical map reorganization enabled by nucleus basalis activity. Science 279, 1714-1718.
54. Klintsova, A.Y., and Greenough, W.T. (1999). Synaptic plasticity in cortical systems. Curr. Opin. Neurobiol. 9, 203-208.
55. Kuo, Y.M., Emmerling, M.R., Vigo-Pelfrey, C., Kasunic, T.C., Kirkpatrick, J.B., Murdoch, G.H., Ball, M.J., and Roher, A.E. (1996). Water-soluble Aβ (N-40, N-42) oligomers in normal and Alzheimer disease brains. J. Biol. Chem. 271, 4077-4081.
56. Lambert, M.P., Barlow, A.K., Chromy, B., Edwards, C., Freed, R., Liosatos, M., Morgan, T.E., Rozovsky, I., Trommer, B., Viola, K.A., et al. (1998). Diffusable, nonfibrillar ligands derived from Aβ 1-42 are potent central nervous system neurotoxins. Proc. Natl. Acad. Sci. USA 95, 6448-6453.
57. Lanahan, A., Lyford, G., Stevenson, G.S., Worley, P.F., and Barnes, C.A. (1997). Selective alteration of long-term potentiation-induced transcriptional response in hippocampus of aged, memory-impaired rats. J. Neurosci. 17, 2876-2885.
58. Levitan, D., Doyle, T.G., Brousseau, D., Lee, M.K., Thinakaran, G., Slunt, H.H., Sisodia, S.S., and Greenwald, I. (1996). Assessment of normal and mutant human presenilin function in Caenorhabditis. roc. Proc. Natl. Acad. Sci. USA 93, 14940-14944.
59. Lin, L.-H., Bock, S., Carpenter, K., Rose, M., and Norden, J.J. (1992). Synthesis and transport of GAP-43 in entorhinal cortex of neurons and perforant pathway during lesion-induced sprouting and reactive synaptogenesis. Mol. Brain Res. 14, 147-153.
60. Linn, R.T., Wolf, P.A., Bachman, D.L., Knoefel, J.E., Cobb, J.L., Belanger, A.J., Kaplan, E.F., and D'Agostino, R.B. (1995). The 'preclinical phase' of probable Alzheimer's disease. A 13-year prospective study of the Framingham cohort. Arch. Neurol. 52, 485-490.
61. Lorenzo, A., Diaz, H., Carrer, H., and Caceres, A. (1992). Amygdala neurons in vitro: neurite growth and effects of estradiol. J. Neurosci. Res. 33, 418-435.
62. Lovestone, S., and Reynolds, C.H. (1997). The phosphorylation of tau: a critical stage in neurodevelopment and neurodegenerative processes. Neuroscience 78, 309-324.
63. Mackenzie, I.R.A., McLachlan, R.S., Kubu, C.S., and Miller, L.A. (1996). Prospective neuropsychological assessment of nondemented patients with biopsy proven senile plaques. Neurology 46, 425-429.
64. Masliah, E., Mallory, M., Hansen, L., Alford, M., Albright, T., DeTeresa, R., Terry, R., Baudier, J., and Saitoh, T. (1991). Patterns of aberrant sprouting in Alzheimer's disease. Neuron 6, 729-739.
65. Masliah, E., Mallory, M., Alford, M., Ge, N., and Mucke, L. (1995). Abnormal synaptic regeneration in hAPP695 transgenic and APOE knockout mice. In Research Advances in Alzheimer's Disease and Related Disorders, K. Iqbal, J.A. Mortimer, B. Winblad, and H.M. Wisniewski, eds. (New York: John Wiley and Sons), pp. 405-414.
66. Masliah, E., Mallory, M., Alford, M., Veinbergs, I., and Roses, A.D. (1996). Apolipoprotein E role in maintaining the integrity of the aging central nervous system. In Apolipoprotein E and Alzheimer's Disease, A.D. Roses, K.H. Weisgraber, and Y. Christen, eds. (Berlin: Springer-Verlag), pp. 59-73.
67. Mattson, M.P. (1997). Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives. Physiol. Rev. 77, 1081-1132.
68. McEwen, B.S., Alves, S.E., Bulloch, K., and Weilan, N.G. (1997). Ovarian steroids and the brain: implications for cognition and aging. Neurology 48 (suppl.), S8-S15.
69. Mesulam, M.-M. (1996). The systems-level organization of cholinergic innervation in the cerebral cortex and its alterations in Alzheimer's disease. Prog. Brain Res. 109, 285-298.
70. Mori, N. (1993). Toward understanding of the molecular basis of loss of neuronal plasticity in ageing. Age Ageing 22, S5-S18.
71. Morris, J.C., Storandt, M., McKeel, D.W., Jr., Rubin, E.H., Price, J.L., Grant, E.A., and Berg, L. (1996). Cerebral amyloid deposition and diffuse plaques in "normal" aging: evidence for presymptomatic and very mild Alzheimer's disease. Neurology 46, 707-719.
72. Morrison, J.H., and Hof, P.R. (1997). Life and death of neurons in the aging brain. Science 278, 412-419.
73. Mucke, L., Masliah, E., Johnson, W.B., Ruppe, M.D., Alford, M., Rockenstein, E.M., Forss-Petter, S., Pietropaolo, M., Mallory, M., and Abraham, C.R. (1994). Synaptotrophic effects of human amyloid β protein precursors in the cortex of transgenic mice. Brain Res. 666, 151-167.
74. Naruse, S., Thinakaran, G., Luo, J.J., Kusiak, J.W., Tomita, T., Iwatsubo, T., Qian, X., Ginty, D.D., Price, D.L., Borchelt, D.R., et al. (1998). Effects of PS1 deficiency on membrane protein trafficking in neurons. Neuron 21, 1213-1221.
75. Nathan, B.P., Bellosta, S., Sanan, D.A., Weisgraber, K.H., Mahley, R.W., and Pitas, R.E. (1994). Differential effects of apolipoproteins E3 and E4 on neuronal growth in vitro. Science 264, 850-852.
76. The National Institute on Aging and the Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's Disease. (1997). Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol. Aging 18, S1-S2.
77. Neill, D. (1995). Alzheimer's disease: maladaptive synaptoplasticity hypothesis. Neurodegeneration 4, 217-232.
78. Neve, R.L., Finch, E.A., Bird, E.D., and Benowitz, L.I. (1988). Growth-associated protein GAP-43 is expressed selectively in associative regions of the adult human brain. Proc. Natl. Acad. Sci. USA 85, 3638-3642.
79. Nitsch, R.M., Slack, B.E., Wurtman, R.J., and Growdon, J.H. (1992). Release of Alzheimer amyloid precursor derivatives stimulated by activation of muscarinic acetylcholine receptors. Science 258, 304-307.
80. Okuno, H., Tokuyama, W., Li, Y.X., Hashimoto, T., and Miyashita, Y. (1999). Quantitative evaluation of neurotrophin and trk mRNA expression in visual and limbic areas along the occipito-temporo-hippocampal pathway in adult macaque monkeys. J. Comp. Neurol. 408, 378-398.
81. Olichney, J.M., Hansen, L.A., Galasko, D., Saitoh, T., Hofstetter, C.R., Katzman, R., and Thal, L.J. (1996). The apolipoprotein E ∈4 allele is associated with increased neuritic plaques and cerebral amyloid angiopathy in Alzheimer's disease and Lewy body variant. Neurology 47, 190-196.
82. Palmert, M.R., Usiak, M., Mayeux, R., Raskind, M., Tourtelotte, W.W., and Younkin, S.G. (1990). Soluble derivatives of the beta amyloid protein precursor in cerebrospinal fluid: alterations in normal aging and in Alzheimer's disease. Neurology 40, 1028-1034.
83. Petersen, R.C., Smith, G.E., Waring, S.C., Ivnik, R.J., Tangalos, E.G., and Kokmen, E. (1999). Mild cognitive impairment. Clinical characterization and outcome. Arch. Neurol. 56, 303-308.
84. Phelps, C.H. (1990). Neural plasticity in aging and Alzheimer's disease: some selected comments. Prog. Brain Res. 86, 3-9.
85. Poirier, J. (1994). Apolipoprotein E in animal models of CNS injury and in Alzheimer's disease. Trends Neurosci. 17, 525-530.
86. Price, B.H., Gurvit, H., Weintraub, S., Geula, C., Leimkuhler, E., and Mesulam, M. (1993). Neuropsychological patterns and language deficits in 20 consecutive cases of autopsy-confirmed Alzheimer's disease. Arch. Neurol. 50, 931-937.
87. Rao, B.S.S., Raju, T.R., and Meti, B.L. (1999). Increased numerical density of synapses in CA3 region of hippocampus and molecular layer of motor cortex after self-stimulation rewarding experience. Neuroscience 91, 799-803.
88. Roch, J.-M., Masliah, E., Roch-Levecq, A.-C., Sundsmo, M.P., Otero, D.A.C., Veinbergs, I., and Saitoh, T. (1994). Increase of synaptic density and memory retention by a peptide representing the trophic domain of the amyloid β/A4 protein precursor. Proc. Natl. Acad. Sci. USA 91, 7450-7454.
89. Roher, A.E., Ball, M.J., Bhave, S.V., and Wakade, A.R. (1991). β-amyloid from Alzheimer disease brains inhibit sprouting and survival of sympathetic neurons. Biochem. Biophys. Res. Commun. 174, 572-579.
90. Roses, A.D. (1997). The predictive value of APOE genotyping in the early diagnosis of dementia of the Alzheimer type: data from three independent series. In Alzheimer's Disease: Biology, Diagnosis and Therapeutics, K. Iqbal, B. Winblad, T. Nishimura, M. Takeda, and H.M. Wisniewski, eds. (New York: John Wiley and Sons), pp. 85-91.
91. Salib, E., and Hillier, V. (1997). Head injury and the risk of Alzheimer's disease: a case control study. Int. J. Geriatr. Psychiatry 12, 363-368.
92. Scheff, S.W., Bernardo, L.S., and Cotman, C.W. (1980). Decline in reactive fiber growth in the dentate gyrus of aged rats as compared to young adult rats following entorhinal cortex removal. Brain Res. 199, 21-38.
93. Scheibel, A.B., and Tomiyasu, U. (1978). Dendritic sprouting in Alzheimer's presenile dementia. Exp. Neurol. 60, 1-8.
94. Selkoe, D.J. (1994). Alzheimer's disease: a central role for amyloid. J. Neuropathol. Exp. Neurol. 53, 438-447.
95. Small, D.H. (1998). The role of the amyloid precursor (APP) in Alzheimer's disease: does the normal function of APP explain the topography of neurodegeneration? Neurochem. Res. 23, 795-806.
96. Small, S.A., Stern, Y., Tang, M., and Mayeux, R. (1999). Selective decline in memory function among healthy elderly. Neurology 52, 1392-1396.
97. Snowdon, D.A., Greiner, L.H., Mortimer, J.A., Riley, K.P., Greiner, P.A., and Markesbery, W.R. (1997). Brain infarction and the clinical expression of Alzheimer's disease. The nun study. JAMA 277, 813-817.
98. Stone, D.J., Rozovsky, I., Morgan, T.E., Anderson, C.P., and Finch, C.E. (1998). Increased synaptic sprouting in response to estrogen via an apolipoprotein E-dependent mechanism: implications for Alzheimer's disease. J. Neurosci. 18, 3180-3185.
99. Storey, E., Beyreuther, K., and Masters, C.L. (1996). Alzheimer's disease amyloid precursor protein on the surface of cortical neurons in primary culture co-localizes with adhesion patch components. Brain Res. 735, 217-231.
100. Takashima, S., Ieshima, A., Nakamura, H., and Becker, L.E. (1989). Dendrites, dementia and the Down syndrome. Brain Dev. 11, 131-133.
101. Terry, R.D., Masliah, E., Salmon, D.P., Butters, N., DeTeresa, R., Hill, R., Hansen, L.A., and Katzman, R. (1991). Physical basis of cognitive alterations in Alzheimer's disease: synapse loss is the major correlate of cognitive impairment. Ann. Neurol. 30, 572-580.
102. Teter, B., Harris-White, M.E., Frautschy, S.A., and Cole, G.M. (1999). Role of apolipoprotein E and estrogen in mossy fiber sprouting in hippocampal slice cultures. Neuroscience 91, 1009-1016.
103. Tokuda, T., Ikeda, S., Yanagisawa, N., Ihara, Y., and Glenner, G.G. (1991). Re-examination of ex-boxer's brains using immunohistochemistry with antibodies to amyloid beta-protein and tau protein. Acta Neuropathol. 82, 280-285.
104. Trojanowski, J.Q., Schmidt, M.L., Shin, R.-W., Bramblett, G.T., Goedert, M., and Lee, V.M.-Y. (1993). From pathological marker to potential mediator of neuronal dysfunction and degeneration in Alzheimer's disease. Clin. Neurosci. 1, 184-191.
105. van Gool, W.A., Schenk, D.B., and Bolhuis, P.A. (1994). Concentrations of beta-amyloid protein in cerebrospinal fluid increase with age in patients free from neurodegenerative disease. Neurosci. Lett. 172, 122-124.
106. Viereck, C., Tucker, R.P., and Matus, A. (1989). The adult rat olfactory system expresses microtubule-associated proteins found in the developing brain. J. Neurosci. 9, 3547-3557.
107. Wallace, W., Ahlers, S.T., Gotlib, J., Bragin, V., Sugar, J., Gluck, R., Shea, P.A., Davis, K.L., and Haroutunian, V. (1993). Amyloid precursor protein in the cerebral cortex is rapidly and persistently induced by loss of subcortical innervation. Proc. Natl. Acad. Sci. USA 90, 8712-8716.
108. Woolley, C.S., Wenzel, H.J., and Schwartzkroin, P.A. (1996). Estradiol increases the frequency of multiple synapse boutons in the hippocampal CA1 region of the adult female rat. J. Comp. Neurol. 373, 108-117.
109. Yankner, B.A. (1996). Mechanisms of neuronal degeneration in Alzheimer's disease. Neuron 16, 921-932.
110. Zhang, Z., Hartmann, H., Do, V.M., Abramowski, D., Struchler-Pierrat, C., Staufenbiel, M., Sommer, B., van de Wetering, M., Clevers, H., Saftig, P., et al. (1998). Destabilization of beta-catenin by mutations in presenilin-1 potentiates neuronal apoptosis. Nature 395, 698-702.
111. Zhu, X.O., and Waite, P.M.E. (1998). Cholinergic depletion reduces plasticity of barrel field cortex. Cereb. Cortex 8, 63-72.